Beta Bionics Inc.
BBNX | NASDAQ
$16.50
-$0.25 (-1.49%)
Nov 2, 2026, 9:43 AM ET · Market open
Market Data
Market Cap $742.42M
Enterprise Value $519.47M
Beta 3.38
Average Volume 1.24M
Shares Outstanding (Diluted) 46.54M
Shares Change YoY 6.66%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US08659B1026
Price Performance
Price Change 1M -13.0%
Price Change 3M 23.6%
Price Change 6M 61.5%
Price Change YTD -45.9%
Price Change 1Y -40.5%
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -23.5%
1Y CAGR (ann.) -37.5%
5Y CAGR (ann.) N/A
All-Time CAGR -17.9%
Valuation
PE Ratio -8.96
Forward PE N/A
PEG Ratio 1.29
Forward PEG -2.32
PS Ratio 5.92
Forward PS 4.10
PB Ratio 1.88
P/FCF Ratio -11.42
P/Adj. FCF Ratio -8.43
P/OCF Ratio -13.09
EV/Sales 4.08
EV/EBIT -5.93
EV/EBITDA -6.15
EV/FCF -7.88
Earnings Yield -11.2%
FCF Yield -8.8%
Adj. FCF Yield -11.9%
Financial Health
Net Cash $234.1M
Total Debt $6.1M
Cash & Short-Term Investments $240.2M
Total Assets $443.76M
Current Ratio 8.92
Quick Ratio 8.22
Debt / Equity Ratio 0.02
Debt / EBITDA -0.07
Debt / FCF -0.09
OCF / Debt -9.73
Interest Coverage 0.00
Altman Z-Score 9.62
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 58.6%
Operating Profit Margin -72.8%
EBITDA Margin -65.4%
Net Profit Margin -65.3%
FCF Margin -51.8%
Adj. FCF Margin -70.3%
SBC / Revenue 18.4%
SBC Impact (per share) -35.5%
Returns
Return on Assets -18.7%
Return on Equity -27.3%
Return on Invested Capital -22.4%
Return on Capital Employed -22.5%
Return on Tangible Assets -18.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 245.2%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -17.2%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -19.8%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 7.8%
Revenue Growth Next 3Y 42.7%
Earnings Date Feb 16, 2027
EPS Estimate (next Q) -$0.50
EPS Growth Est (next Q) 66.7%
Revenue Est (next Q) $31.14M
Revenue Growth Est (next Q) -3.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $24.67
Price Target Upside 47.3%
Cash Flow
Operating Cash Flow $-59.37M
Free Cash Flow $-65.96M
Adj. Free Cash Flow $-89.4M
FCF Per Share -$1.42
OCF Per Share -$1.28
OCF/S Ratio -46.6%
Income Statement
Revenue $127.27M
Gross Profit $74.61M
Operating Income $-92.58M
EBITDA $-84.51M
Net Income $-83.12M
EPS (Diluted) -$1.87
Revenue / Employee $301.58K
Profit / Employee $-196.96K
Employees 422
Add to Watchlist
Select watchlists to add or remove BBNX